Navigating the Dotted Line
Transforming pricing and contract management practices often appears to be easier said than done, but it’s worth the effort—and it’s achievable. Read this article to learn how to get started.
Pharma Biotech IPR Infographic 2016
Tailoring effective incentive compensation plans can be tough in all therapeutic areas, but oncology presents even more of a challenge given its extremely complicated market with frequent changes, small patient populations, low sales volume and products that are used across multiple indications.
Hidden Dangers Lurking In Your Comp Plan
Based on the Explorer Study, this infographic shows that when companies
invest in a sales transformation across several prioritized SFE
initiatives, they can improve their performance by up to 23% within one
year across a number of metrics.
ZS Oncology Value Watchdog Report: Oncology Care Model
This issue of the ZS Oncology Value Watchdog Report summarizes discussions about value that took place at the 2015 ASH conference. It also includes data from the ZS Value and Oncology Practice Management survey of MDs.
Broken links: Why analytics investments have yet to pay off
This EIU study, "Broken links: Why analytics investments have yet to pay off," sponsored by ZS, draws on survey findings, interviews with senior corporate executives and desk research to explore the current state of sales and marketing analytics.
Displaying 1 - 15 of 456